Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Knopman

Showing results (31-40 of 44) with videos related to

Pageof 5
Sort By:
Neurology|December 1, 1996
A multicenter double-blind study of controlled-release physostigmine for the treatment of symptoms secondary to Alzheimer's disease. Physostigmine Study GroupL J Thal, G Schwartz, M Sano, et al.
Journal of Clinical and Experimental Neuropsychology|May 15, 2007
Mayo's Older Americans Normative Studies: Visual Form Discrimination and copy trial of the Rey-Osterrieth Complex FigureM M Machulda, R J Ivnik, G E Smith, et al.
Neurology|February 13, 2003
Mild cognitive impairment in the oldest oldB Boeve, J McCormick, G Smith, et al.
Neurology|January 28, 2004
DLB fluctuations: specific features that reliably differentiate DLB from AD and normal agingT J Ferman, G E Smith, B F Boeve, et al.
Alzheimer Disease and Associated Disorders|January 1, 1997
Development of cognitive instruments for use in clinical trials of antidementia drugs: additions to the Alzheimer's Disease Assessment Scale that broaden its scope. The Alzheimer's Disease Cooperative StudyR C Mohs, D Knopman, R C Petersen, et al.
Neurology|January 29, 2003
MRI as a biomarker of disease progression in a therapeutic trial of milameline for ADC R Jack, M Slomkowski, S Gracon, et al.
Neurology|September 16, 2009
Retinal microvascular abnormalities and cognitive decline: the ARIC 14-year follow-up studyS R Lesage, T H Mosley, T Y Wong, et al.
Neurology|April 12, 2012
Similar clinical and neuroimaging features in monozygotic twin pair with mutation in progranulinE McDade, B F Boeve, T M Burrus, et al.
Nature Communications|March 29, 2022
A computational model of neurodegeneration in Alzheimer's diseaseD Jones, V Lowe, J Graff-Radford, et al.
Archives of Neurology|July 25, 1998
High cerebrospinal fluid tau and low amyloid beta42 levels in the clinical diagnosis of Alzheimer disease and relation to apolipoprotein E genotypeD Galasko, L Chang, R Motter, et al.
Pageof 5

Showing results (31-40 of 44) with videos related to

Sort By:
Pageof 5
Neurology|December 1, 1996
A multicenter double-blind study of controlled-release physostigmine for the treatment of symptoms secondary to Alzheimer's disease. Physostigmine Study GroupL J Thal, G Schwartz, M Sano, et al.
Journal of Clinical and Experimental Neuropsychology|May 15, 2007
Mayo's Older Americans Normative Studies: Visual Form Discrimination and copy trial of the Rey-Osterrieth Complex FigureM M Machulda, R J Ivnik, G E Smith, et al.
Neurology|February 13, 2003
Mild cognitive impairment in the oldest oldB Boeve, J McCormick, G Smith, et al.
Neurology|January 28, 2004
DLB fluctuations: specific features that reliably differentiate DLB from AD and normal agingT J Ferman, G E Smith, B F Boeve, et al.
Alzheimer Disease and Associated Disorders|January 1, 1997
Development of cognitive instruments for use in clinical trials of antidementia drugs: additions to the Alzheimer's Disease Assessment Scale that broaden its scope. The Alzheimer's Disease Cooperative StudyR C Mohs, D Knopman, R C Petersen, et al.
Neurology|January 29, 2003
MRI as a biomarker of disease progression in a therapeutic trial of milameline for ADC R Jack, M Slomkowski, S Gracon, et al.
Neurology|September 16, 2009
Retinal microvascular abnormalities and cognitive decline: the ARIC 14-year follow-up studyS R Lesage, T H Mosley, T Y Wong, et al.
Neurology|April 12, 2012
Similar clinical and neuroimaging features in monozygotic twin pair with mutation in progranulinE McDade, B F Boeve, T M Burrus, et al.
Nature Communications|March 29, 2022
A computational model of neurodegeneration in Alzheimer's diseaseD Jones, V Lowe, J Graff-Radford, et al.
Archives of Neurology|July 25, 1998
High cerebrospinal fluid tau and low amyloid beta42 levels in the clinical diagnosis of Alzheimer disease and relation to apolipoprotein E genotypeD Galasko, L Chang, R Motter, et al.
Pageof 5